Check Cap Ltd CHEK:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 8:37 AM EDT
2.24UNCH (UNCH)
Volume
112
Close
2.24quote price arrow up+0.10 (+4.56%)
Volume
112
52 week range
1.41 - 4.62
Loading...
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close2.24
  • 52 Week High4.62
  • 52 Week High Date09/21/23
  • 52 Week Low1.41
  • 52 Week Low Date05/26/23

Key Stats

  • Market Cap13.088M
  • Shares Out5.85M
  • 10 Day Average Volume0.00M
  • Dividend-
  • Dividend Yield-
  • Beta0.16
  • YTD % Change7.58

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close2.24
  • 52 Week High4.62
  • 52 Week High Date09/21/23
  • 52 Week Low1.41
  • 52 Week Low Date05/26/23
  • Market Cap13.088M
  • Shares Out5.85M
  • 10 Day Average Volume0.00M
  • Dividend-
  • Dividend Yield-
  • Beta0.16
  • YTD % Change7.58

RATIOS/PROFITABILITY

  • EPS (TTM)-3.01
  • P/E (TTM)-0.74
  • Fwd P/E (NTM)-1.62
  • EBITDA (TTM)-17.651M
  • ROE (TTM)-48.74%
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date08/13/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Check Cap Ltd

 

Content From Our Affiliates

Profile

MORE
Check Cap Ltd is an Israel-based clinical-stage medical diagnostics company. Check Cap Ltd develops C-Scan, patient-friendly preparation-free test designed to detect polyps before they may transform into cancer to enable early intervention and cancer prevention. It's capsule-based screening technology aims to increase screening adherence worldwide. The system utilizes ultra-low-dose X- rays to scan the inner lining of the colon for precancerous polyps, and other structural...
Steven Hanley
Chairman of the Board
Alex Ovadia
Chief Executive Officer
Dan Hilerowitz
Chief Financial Officer
Yoav Kimchy Ph.D.
Chief Technology Officer
Hanit Brenner-lavie
Vice President - Clinical Affairs
Address
29 Abba Hushi Ave., Isfiya
P.O.Box 1271
3009000
Israel